Acute monocytic leukemia News and Research

RSS
Eighteen scientists receive Damon Runyon Cancer Research Foundation awards

Eighteen scientists receive Damon Runyon Cancer Research Foundation awards

7 Jul 2011
FDA responds to EpiCept Ceplene SPA

FDA responds to EpiCept Ceplene SPA

27 Jun 2011
Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

14 Jun 2011
Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma

Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma

13 Jun 2011
Ambit Biosciences raises $30 million through Series D-2 equity financing

Ambit Biosciences raises $30 million through Series D-2 equity financing

10 Jun 2011
Dacogen Phase III study results on acute myeloid leukemia presented at ASCO 2011

Dacogen Phase III study results on acute myeloid leukemia presented at ASCO 2011

7 Jun 2011
FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

7 Jun 2011
Positive results from Celator CPX-351 Phase 2b study on acute myeloid leukemia presented at ASCO

Positive results from Celator CPX-351 Phase 2b study on acute myeloid leukemia presented at ASCO

7 Jun 2011
Interim results from CTI, Chroma Therapeutics' tosedostat phase II trial on AML presented at ASCO

Interim results from CTI, Chroma Therapeutics' tosedostat phase II trial on AML presented at ASCO

6 Jun 2011
Key findings from Phase I clinical trial of CPI-613 in AML to be presented at ASCO 2011

Key findings from Phase I clinical trial of CPI-613 in AML to be presented at ASCO 2011

4 Jun 2011
ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

3 Jun 2011
New study sheds light on origins of myeloid leukemia

New study sheds light on origins of myeloid leukemia

13 May 2011
Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

12 May 2011
Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

11 May 2011
ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

20 Apr 2011
Sequencing the genomes of cancer patients help doctors decide the best course of treatment

Sequencing the genomes of cancer patients help doctors decide the best course of treatment

20 Apr 2011
NCI, ASH, AMEH join to improve care for patients with AML

NCI, ASH, AMEH join to improve care for patients with AML

11 Apr 2011
Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

8 Apr 2011
Researchers develop new drug for multiple cancer treatment

Researchers develop new drug for multiple cancer treatment

30 Mar 2011
Sequencing mouse cancer genome reveals mutations driving cancer in humans

Sequencing mouse cancer genome reveals mutations driving cancer in humans

24 Mar 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback